Drug Shortage Report for MAR-LETROZOLE
Report ID | 82881 |
Drug Identification Number | 02373424 |
Brand name | MAR-LETROZOLE |
Common or Proper name | Letrozole |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | LETROZOLE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 Tablets |
ATC code | L02BG |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-04-28 |
Estimated end date | 2019-05-01 |
Actual end date | 2019-05-01 |
Shortage status | Resolved |
Updated date | 2019-05-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-05-02 | English | Compare |
v4 | 2019-05-01 | French | Compare |
v3 | 2019-05-01 | English | Compare |
v2 | 2019-04-30 | French | Compare |
v1 | 2019-04-30 | English | Compare |
Showing 1 to 5 of 5